
FDA approves first twice-yearly injection that prevents HIV infection
Fox News
The FDA has approved Yetzugo, Gilead Sciences' twice-yearly injectable HIV prevention treatment, which showed nearly 100% effectiveness in clinical trials.
Khloe Quill is a lifestyle production assistant with Fox News Digital. She and the lifestyle team cover a range of story topics including food and drink, travel, and health.
"This is a historic day in the decades-long fight against HIV," said Daniel O’Day, chairman and CEO of California-based Gilead Sciences, in a press release.
More Related News













